-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Sporadic Creutzfeldt-Jakob Disease
Urine Test for Creutzfeldt-Jakob Disease (CJD)? (BBC News / MRC / JAMA Neurology / NEJM)
Summary It may one day be possible to use a non-invasive diagnostic urine test to discover whether or not patients have sporadic Creutzfeldt-Jakob Disease (sCJD). Full Text Link Reference A urine test for Creutzfeldt-Jakob Disease may be possible. London: Medical … Continue reading →
Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, UK, Universal Interest
|
Tagged Abnormal Prion Protein, Abnormal Prion Protein in Urine, Abnormal Proteins (Prions), Assistance Publique-Hôpitaux de Paris: Cellule Nationale de Référence des Maladies de Creutzfeldt-Jakob, BBC Health News, Biomarkers, Blood and Urine Biomarkers, Case Western Reserve University, Centre Nationale de la Recherche Scientifique, Creutzfeldt-Jakob Disease (CJD), Creutzfeldt-Jakob Disease Incidence in the UK (By Calendar Year), Dementia Research Centre: University College London Institute of Neurology, Department of Neurodegenerative Disease: University College London, Department of Neurodegenerative Disease: University College London Institute of Neurology, Diagnosis of Sporadic Creutzfeldt-Jakob Disease Via Abnormal Prion Protein in Urine, Foundation Carlo Besta Neurologic Institute (Milan), Groupe Hospitalier Pitié-Salpêtrière: INSERM, INSERM, JAMA Neurology, Medical Research Council (MRC), Medical Research Council Prion Unit, Misfolded Proteins, Mitchell Center for Research in Alzheimer's Disease and Related Brain Disorders: University of Texas Medical School at Houston, MRC Prion Unit, MRC Prion Unit and Department of Neurodegenerative Disease: UCL Institute of Neurology, MRC Prion Unit: UCL Institute of Neurology, MRC Prion Unit: University College London, MRC: Medical Research Council, National CJD Research and Surveillance Unit (NCJDRSU), National CJD Research and Surveillance Unit: University of Edinburgh, National Hospital for Neurology and Neurosurgery: University College London Hospitals NHS Foundation Trust, National Prion Clinic: University College London Hospitals NHS Foundation Trust, National Prion Disease Pathology Surveillance Center: Case Western Reserve University, Neurodegenerative Disease Research, Neurodegenerative Diseases, New England Journal of Medicine, Non-Invasive Biomarkers, Partially-Protease Resistant Isoform (PrP(Sc)), Potential Urine Test for Creutzfeldt-Jakob Disease, Prion Diseases, Prion Protein, Protein Misfolding, Protein Misfolding Cyclic Amplification (PMCA), Sporadic Creutzfeldt-Jakob Disease, sporadic Creutzfeldt-Jakob Disease (sCJD), Unité Mixte de Recherche, Universidad de los Andes: Facultad de Medicina, Université Pierre et Marie Curie-Paris 6, University College London (UCL), University College London Hospitals NHS Foundation Trust, University College London Institute of Neurology, University of Edinburgh, University of Texas Medical School at Houston, Urine Tests, Variant CJD, Variant Creutzfeldt-Jakob Disease, Western General Hospital
|
Leave a comment
Early Diagnosis of Parkinson’s Disease and DLB Using CSF Biomarker? (BBC News / Annals of Clinical and Translational Neurology)
Summary Research at the University of Edinburgh indicates that test for synuclein, which measures how sticky this protein molecule has become (i.e. alpha-synuclein aggregation), might be the key to diagnosing accurately the early stages of both Parkinson’s Disease and Dementia … Continue reading →
Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Parkinson's Disease, Scotland, UK, Universal Interest
|
Tagged Abnormal Proteins (Alpha-Synuclein), Alpha-Synuclein Aggregation, Alpha-Synuclein RT-QuIC, Alpha-Synucleinopathies, Annals of Clinical and Translational Neurology, BBC Health News, Biomarker Development, Biomarkers, Biomarkers Research Programmes, Brain Bank Network (MRC), Brains for Dementia Research (BDR), Centre for Clinical Brain Sciences: Western General Hospital, Cerebrospinal Fluid Biomarkers for Parkinson's Disease Diagnosis, Creutzfeldt Jacob Disease (CJD), Creutzfeldt-Jakob Disease (CJD), Creutzfeldt-Jakob Disease in United Kingdom Patients Treated With Human Pituitary Growth Hormone, CSF Biomarkers, Dementia With Lewy Bodies (DLB), Department of Physiology Anatomy and Genetics: University of Oxford, Diagnosis, Diagnosis and Screening: Dementia with Lewy Bodies, Differential Diagnosis, DLB: Dementia with Lewy Bodies, Early Diagnosis, Early Diagnosis of Lewy Body Dementia (LBD), Early Diagnosis of Parkinson’s Disease, Early Diagnosis of Parkinson’s Disease and DLB, Edinburgh Brain Bank, α-Synuclein, α-Synuclein Aggregation, α-Synuclein Misfolds, John Radcliffe Hospital, Lewy Body Degeneration, Lewy Body Dementia, Lewy Body Dementia (LBD), Medical Research Council (MRC), Michael J Fox Foundation, Misfolded Proteins, Monument Trust Discovery Award (Parkinson's UK), MRC Brain Bank, National CJD Research and Surveillance Unit (NCJDRSU), National CJD Surveillance Unit: Western General Hospital: Data Release (HSCIC), National Institute for Health Research (NIHR), National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, NCJDRSU: National CJD Research and Surveillance Unit, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Nuffield Department of Clinical Neurosciences: University of Oxford, OPDC Discovery Cohort, OPTIMA Cohort, OPTIMA Cohort (Oxford Project to Investigate Memory and Ageing), Oxford Brain Bank, Oxford Parkinson's Disease Centre, Oxford Parkinson's Disease Centre (OPDC) Discovery Study, Oxford Parkinson's Disease Centre: University of Oxford, Preclinical Biomarkers and Dementia, Prion-Like Mechanisms, Real-Time Quaking-Induced Conversion (RT-QuIC) Based Assay, Scottish Government's Chief Scientists Office, Sporadic Creutzfeldt-Jakob Disease, Synucleinopathies, Synucleinopathy, Synucleinopathy Progression, UK Brain Banks Network, UK Parkinson’s Disease Society Brain Bank Clinical Diagnostic Criteria, Underlying Mechanisms of DLB Pathogenesis, University of Edinburgh, University of Oxford, Western General Hospital: Edinburgh
|
Leave a comment
The Epidemiology, Diagnosis and Management of CJD in the UK (Public Health England / NCJDRSU)
Summary “Creutzfeldt-Jakob disease (CJD) is a rare and ultimately fatal degenerative brain disease. It is one of a group of diseases called Transmissible Spongiform Encephalopathies (TSEs)”. Health Protection Agency (HPA): Part of Public Health England (Since April 2013) Information sources concerning … Continue reading →
Posted in Acute Hospitals, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), National, Patient Care Pathway, Proposed for Next Newsletter, Public Health England, Quick Insights, UK, Universal Interest
|
Tagged Abnormal Prion Protein, Assessment and Diagnosis, Brain Banking, Brain Specific Proteins, CJD, CJD and TSE Occupational Exposures, CJD Incidents Panel, CJD Risk Analyses and Assessments, Clinical Surveillance, Creutzfeldt-Jakob Disease (CJD), Creuzfeldt Jacob Disease (CJD), CSF 14-3-3, Diagnosis, Differential Diagnosis, Edinburgh, Epidemiology, Health Protection Agency (HPA), Iatrogenic CJD, Iatrogenic Creutzfeldt-Jakob Disease, Molecular Genetics, National Care Team (CJD), National CJD Research and Surveillance Unit (NCJDRSU), National Prion Clinic, NCJDRSU: National CJD Research and Surveillance Unit, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neuropathology, PIND: Progressive Intellectual and Neurological Deterioration, Prevalence of CJD, Prion Diseases, Prion Protein, Prion Protein Laboratory, Progressive Intellectual and Neurological Deterioration (PIND), Referrals, Registry for CJD and TSE Occupational Exposures, Sporadic CJD, Sporadic Creutzfeldt-Jakob Disease, Surveillance, Transfusion Medicine Epidemiology Review, Transfusion Medicine Epidemiology Review (TMER), Transmissible Spongiform Encephalopathies (TSEs), UK Blood Services (UKBS), University of Edinburgh, Variant CJD, Variant CJD and Blood, Variant Creutzfeldt-Jakob Disease, vCJD Infection, Western General Hospital: Edinburgh
|
Leave a comment
